Bayer to buy AskBIo in deal worth up to $4 billion
October 26, 2020 at 08:55 AM EDT
A global pharmaceutical company is buying a Triangle-based gene-therapy outfit in a deal that could reach as high as $4 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|